Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients [Phase 1, Phase 2]
Phase IB/II study evaluating ribociclib in combination with trastuzumab and letrozole in postmenopausal HR+, HER2-positive advanced breast c…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC [Phase 3]
Phase 3 trial evaluating ribociclib with letrozole for HR+ HER2- advanced breast cancer in men and pre/postmenopausal women has completed wi…
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer [Phase 2]
Phase 2 trial evaluating avoidance of growth factor support during paclitaxel treatment in early stage breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide [Phase 2]
Phase 2 open-label study evaluating the incidence and severity of diarrhea in early-stage HER2-positive breast cancer patients treated with …
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer [Phase 3]
A Phase 3 randomized trial evaluating adjuvant progesterone and vitamin D3 in women with locally advanced or large operable breast cancer; t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03] [Phase 3]
Phase 3 DESTINY-Breast03 compared trastuzumab deruxtecan (DS-8201a) with ado-trastuzumab emtansine (T-DM1) in HER2-positive unresectable/met…
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer. [Phase 2]
Phase 2 neoadjuvant therapy study for clinically staged I-III HER2-positive breast cancer; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer [Phase 2]
Phase 2 trial evaluating the efficacy and safety of the combination of sintilimab and apatinib with chemotherapy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients [Phase 3]
Phase 3 trial evaluating tamoxifen efficacy in ER/PR-negative, ER-beta positive operable breast cancer patients is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer [Phase 2]
Phase 2 trial update exploring continuous combination of pegylated liposomal doxorubicin (PLD) with cyclophosphamide and Nab-Paclitaxel in H…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial update evaluating pyrotinib in combination with vinorelbine for HER2-positive locally advanced or metastatic breast…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: HER2-positive Breast Cancer Project Initiated by Investigators [Phase 2]
Investigator-initiated Phase 2 clinical trial update for HER2-positive breast cancer involving Fudan University.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab [Phase 3]
Phase 3 trial investigating rechallenge with pyro tinib in HER2-positive metastatic breast cancer previously treated with pyrotinib and tras…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer [Phase 1]
Phase 1 trial investigating eribulin mesylate and everolimus in triple-negative metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) [Phase 3]
Phase 3 trial comparing ABX plus cisplatin to gemcitabine plus cisplatin in triple-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow [Phase 2]
Phase 2 clinical trial update investigating secondary adjuvant treatment for patients with isolated tumor cells in bone marrow in breast can…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer [Phase 3]
A phase 3 trial comparing the combination of TC plus Bevacizumab to TC alone and to TAC in women with node-positive or high-risk node-negati…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis [Phase 3]
A Phase 3 trial evaluated adding mirtazapine to dexamethasone and aprepitant for delayed emesis in breast cancer patients; the study has com…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer [Phase 2]
Phase 2 trial update on palbociclib with ovarian suppression and letrozole as neoadjuvant treatment for breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Metronomic PLD in Patients With Primary Endocrine Resistant ABC [Phase 2]
Phase 2 clinical trial update for metronomic pegylated liposomal doxorubicin (PLD) in patients with primary endocrine-resistant advanced bre…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Platinum Rechallenge in Patients With Platinum-sensitive mTNBC [Phase 2]
Phase 2 clinical trial evaluating platinum rechallenge in patients with platinum-sensitive metastatic triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: ImmunoBreast - A Phase Ib Study [Phase 1, Phase 2]
Phase I/II clinical trial update for ImmunoBreast in breast cancer, including triple-negative and metastatic disease, with unspecified statu…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC) [Phase 2]
Phase 2 trial comparing gemcitabine plus cisplatin vs gemcitabine plus carboplatin in triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: DP303c in Patients With HER2-positive Unresectable Locally Advanced, Relapsed, or Metastaticbreast Cancer [Phase 2]
Phase 2 trial update for DP303c in HER2-positive unresectable locally advanced, relapsed, or metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: The HeartSpare Plus 1B Trial [Phase 2]
Phase 2 trial update for HeartSpare Plus 1B in breast cancer has completed.